- Home
- GPRE vs ALVO Comparison
GPRE vs ALVO Comparison
Compare GPRE & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GPRE | ALVO |
|---|---|---|
| Founded | 2004 | 2013 |
| Country | United States | Luxembourg |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 2004 | 2021 |
Fundamental Metrics
Financial Performance| Metric | GPRE | ALVO |
|---|---|---|
| Price | $15.93 | $5.30 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $12.57 | $8.00 |
| AVG Volume (30 Days) | ★ 1.4M | 999.0K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.25 | N/A |
| Revenue | ★ $2,091,680,000.00 | N/A |
| Revenue This Year | N/A | $13.28 |
| Revenue Next Year | $11.85 | $18.63 |
| P/E Ratio | ★ $12.36 | $18.20 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.65 | $2.94 |
| 52 Week High | $19.65 | $9.25 |
Technical Indicators
Market Signals| Indicator | GPRE | ALVO |
|---|---|---|
| Relative Strength Index (RSI) | 53.90 | 74.12 |
| Support Level | $13.89 | $4.46 |
| Resistance Level | $16.65 | $5.44 |
| Average True Range (ATR) | 0.82 | 0.29 |
| MACD | 0.09 | 0.05 |
| Stochastic Oscillator | 79.08 | 89.83 |
Price Performance
Historical ComparisonAbout GPRE Green Plains Inc.
Green Plains Inc manufactures and sells ethanol and ethanol byproducts in two segments based on function. The ethanol production segment, which generates the majority of revenue, includes the production of ethanol, distillers grains, Ultra-High Protein and renewable corn oil. The agribusiness and energy services segment includes grain handling and storage, commodity marketing and merchant trading for company-produced and third-party ethanol, distillers grains, Ultra-High Protein, renewable corn oil, natural gas and other commodities.
About ALVO Alvotech
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.